Check out our most popular compounded medications! Get Started
Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects and improved patient compliance. These capsules are used to treat conditions such as Ischemic Peripheral Vascular Disease, Intermittent Claudication, Raynaud's Syndrome, Chronic Venous Insufficiency, and Atherosclerosis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) is a compounded medication specifically designed to treat conditions related to ischemic peripheral vascular disease, intermittent claudication, Raynaud's syndrome, chronic venous insufficiency, and atherosclerosis. This medication works by enhancing the flexibility of red blood cells, thereby improving blood flow and reducing inflammation.
This particular formulation is compounded with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
By providing a steady release of Pentoxifylline, this formulation allows for more consistent therapeutic effects, which can help improve circulation, reduce inflammation, and decrease the risk of further complications. As with all medications, it is important that patients take Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) as directed by their healthcare provider.
At Bayview Pharmacy, we are dedicated to providing our patients with the highest quality of care. We understand that each patient is unique and that their medication needs may vary. Therefore, we offer a wide range of compounded medications, including Pentoxifylline 400 mg Slow Release Capsules (Gluten Free), to meet the diverse needs of our patients. If you have any questions about this medication or any other aspect of your treatment, please do not hesitate to reach out to us. We are here to assist you in finding the best treatment for your condition.
Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) are meticulously formulated with Methocel E4M, a type of controlled-release polymer. This advanced formulation is designed to gradually release the encapsulated medication or active ingredient over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
It functions by enhancing blood flow to the affected areas, reducing inflammation, and improving the elasticity of the blood vessels.
Pentoxifylline has been demonstrated to alleviate symptoms of intermittent claudication, such as pain and cramping in the legs, and to improve walking distance. It has also been shown to reduce the frequency and severity of Raynaud's Syndrome attacks.
Notably, Pentoxifylline has been shown to reduce the risk of atherosclerosis, a condition characterized by the buildup of plaque in the arteries, leading to an increased risk of heart attack and stroke. If you have any questions about using Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) to treat any of these conditions, please do not hesitate to reach out for further information.
Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) are a specialized medication designed to treat conditions related to poor circulation, such as Ischemic Peripheral Vascular Disease, Intermittent Claudication, Raynaud's Syndrome, Chronic Venous Insufficiency, and Atherosclerosis. The capsules are formulated with Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the active ingredient over an extended period of time. This slow release formulation offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance for medications requiring a controlled and prolonged release profile.
The medication works by reducing the viscosity of the blood, enhancing its flow through the vessels, and thereby alleviating symptoms associated with these conditions, such as pain, numbness, and fatigue. The capsules are gluten-free, making them suitable for individuals with gluten sensitivities.
When taking Pentoxifylline 400 mg Slow Release Capsules, it is crucial to follow the prescribed dosage by your healthcare provider. The capsules should be taken with food and at the same time each day to ensure optimal effectiveness. Adequate hydration is also important while on this medication as it can cause dehydration.
It's important to understand that Pentoxifylline 400 mg Slow Release Capsules may take several weeks to start working, and the full effects may not be evident for several months. Potential side effects may include nausea, vomiting, headache, dizziness, and diarrhea. If you experience any of these side effects, it is important to contact your healthcare provider immediately.
If you have any questions about Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) or how it can help treat your condition, don't hesitate to reach out. We are here to assist you in understanding your medication and its benefits.
Pentoxifylline 400 mg Slow Release Capsules (Gluten Free) are formulated with Methocel E4M, a type of controlled-release polymer. This design allows for the gradual release of the encapsulated medication or active ingredient over an extended period of time. This sustained release offers prolonged therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
These capsules may be used to treat a variety of conditions. They have been used in the management of diabetic neuropathy and scleroderma, as well as in the treatment of chronic obstructive pulmonary disease (COPD). Pentoxifylline has also been utilized to reduce the risk of stroke in patients with atrial fibrillation.
Furthermore, pentoxifylline has been employed to mitigate the risk of contrast-induced nephropathy in patients undergoing coronary angiography. It has also been used to decrease the risk of postoperative complications in patients undergoing cardiac, abdominal, or orthopedic surgery.
If you have any questions about the use of pentoxifylline for any of these conditions, please do not hesitate to reach out for further information.
Pentoxifylline 400 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the medication over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
Yes, Pentoxifylline 400 mg Slow Release Capsules is a gluten-free medication. This makes it suitable for individuals with gluten intolerance or celiac disease.
The slow release formulation of Pentoxifylline 400 mg reduces the frequency of dosing. However, the exact dosing schedule will depend on your doctor's prescription and your specific medical condition.
Pentoxifylline 400 mg Slow Release Capsules offers sustained therapeutic effects due to its slow release formulation. The exact therapeutic effects will depend on the condition it is being used to treat.
While Pentoxifylline 400 mg Slow Release Capsules is a medication that offers several benefits, it should only be taken under the supervision of a healthcare professional. Your doctor will determine if this medication is suitable for you based on your specific medical condition and overall health.
No, the slow release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period of time.
No, Pentoxifylline 400 mg Slow Release Capsules should not be broken or crushed. Doing so can interfere with the controlled-release mechanism and may lead to a sudden release of the medication, which can have adverse effects.
If you miss a dose of Pentoxifylline 400 mg Slow Release Capsules, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double up on doses to make up for a missed one.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
